ACS San Diego 2019: Day 4

Throughout this week, RxNet is bringing you content, direct from the ACS San Diego 2019 (25–29 August 2019; CA, USA). Take a look at some of the highlights, including some of the key presentations and news from the meeting.

Like 0 Comment

Today’s key talks

  1. SYMPOSIA: First time disclosure of clinical candidates (Wednesday, 28 August; 8:15 AM —12:10 PM)
  2. Discovery and development of a novel, class I Core protein Assembly Modulator (CpAM) for the treatment of chronic HBV infection (Wednesday, 28 August; 2:05 – 2:35 PM) – Wei Zhu (Roche RD Center; Shanghai, China)

Catch up on news from the conference

Could this microneedle skin patch be a better alternative to ointments and injections?

Remodeling the microbiome for atherosclerosis therapy

Neuroprotective peptide hydrogel to treat traumatic brain injuries

What to look out for tomorrow

  1. “Smart” DNA-based materials for controlled release (Thursday, 29 August; 9:00—9:30 AM) – Margarita Vazquez (Hebrew University of Jerusalem; Israel) 
  2. Micromotors as targeted payload delivery platforms (Thursday, 29 August; 11:20—11:40 AM) – Emil Karshalev (University of California, San Diego; USA) 
Go to the profile of RxNet


A network for the drug discovery and development community, Future Science Group

Your source for the latest news and views from the fields of drug discovery and medicinal chemistry.

No comments yet.